Troy D. Weaver sold $393k of AXTA
President, Global Refinish at Axalta Coating Systems Ltd.. 10,457 shares at an average of $37.57, traded Feb 10, 2025, filed Feb 12, 2025.
Score components
- +20RolePresident
- +16Trade size$393k at market
- +5Share of holdings soldSold 12% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-25-005229, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 10, 2025 | MOption exercise Common Shares | +10,457 | $32.50 | $340k | 85,362 | Feb 12, 2025 |
| Feb 10, 2025 | SOpen-market sale Common Shares | -10,457 | $37.57 | $393k | 74,905 | Feb 12, 2025 |
| Feb 10, 2025 | MOption exercise Employee Stock Optionderivative | -10,457 | $0.00 | $0 | 0 | Feb 12, 2025 |
Related signals
Other insiders at Axalta Coating Systems Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | AXTAsell Axalta Coating Systems Ltd. | Amy Tufano SVP & CHRO | $99k 3,194 shares | -21% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.